About Avenda Health
Avenda Health is a healthcare AI company dedicated to revolutionizing prostate cancer care through advanced technology. Their flagship product, Unfold AI, is an FDA-cleared, AI-powered decision support platform that generates personalized 3D maps of prostate cancer. This platform integrates patient-specific diagnostic data, including MRI, pathology, biomarkers, and clinical information, to visualize the extent and location of cancer within the prostate.
For physicians, Unfold AI offers a powerful tool to enhance diagnostic accuracy and treatment planning. It aims to provide precise information that can inform surgical decision-making, guide repeat biopsies for active surveillance, determine the extent of prostate to treat in focal therapy, and identify areas for focused radiation in radiotherapy. Studies have shown that AI-assisted cancer identification with Unfold AI can significantly improve urologists’ and radiologists’ abilities in identifying cancer extent, outperforming conventional methods like MRI in predicting tumor margins and true tumor volume. The company’s goal is to improve patient outcomes, preserve quality of life, and establish a new standard of personalized and precise cancer care.
Focus Areas
Business Intelligence
| Technology | Cloud-native, deep learning (convolutional neural networks), gradient boosted decision trees, voxel-wise probability mapping, 3D cancer estimation map generation, MRI image registration to pathology, whole-mount pathology correlation, cloud architecture for clinical software, statistical validation metrics, clinical decision support reporting |
What Physicians Need to Know
Avenda Health's Unfold AI platform offers physicians a powerful tool to enhance prostate cancer care. It provides a highly accurate, personalized 3D map of the cancer, integrating MRI, biopsy, pathology, and clinical data. This detailed visualization improves the ability to identify the extent of the tumor by 45x and can lead to more confident treatment decisions, potentially shifting recommendations towards more localized and less invasive options in a significant percentage of cases. The platform supports the entire care continuum, from active surveillance to planning for surgical interventions, radiotherapy, and focal therapy, helping to preserve patient quality of life. Unfold AI is FDA-cleared and backed by established billing pathways, including a Category III CPT code and a national Medicare payment rate for outpatient hospital settings.
Avenda Health's Unfold AI platform is designed to integrate patient-specific data from standard-of-care diagnostics, including MRI, biopsies, and pathology. It has been successfully integrated with other technologies, such as the PrecisionPoint® Transperineal Access System for safer and more precise biopsies. Additionally, Avenda Health has collaborated with EDAP TMS to launch AI-assisted Focal One® robotic HIFU procedures, combining Unfold AI's planning with Focal One's HIFUsion® software for tailored ablation. The platform is cloud-delivered and offers physician deployment and integration services to incorporate AI decision support into clinical workflows.
What the Web Says
Avenda Health is a healthcare technology company that focuses on transforming prostate cancer treatment through advanced imaging and artificial intelligence, specifically with their Unfold AI platform. The company's technology aims to provide precise prostate cancer mapping and focal laser ablation, potentially allowing for in-office treatments with minimal side effects and preserving patients' quality of life. While there is significant information about their product and its clinical validation, direct user reviews from platforms like G2, Glassdoor, Capterra, and Reddit are limited or non-existent for Avenda Health specifically.
Overall: PositiveStrengths
- AI-powered prostate cancer mapping for precise treatment.
- Potential for in-office treatment with local anesthesia, reducing complications and recovery time.
- Aims to preserve patient quality of life by sparing healthy tissue.
- FDA Breakthrough Device status and 510(k) clearance for Unfold AI.
- Validated in multiple clinical studies, showing improved tumor margin creation.
- Addresses a significant clinical need in prostate cancer care.
Limitations
- Lack of readily available product reviews from G2, Capterra, or Reddit.
- Limited public employee reviews on platforms like Glassdoor.
- No specific negative feedback identified in the search results.
- Average annual salary for employees is an estimation and not from factual payroll records.
- The company's API has low scores in several quality facets, including contract quality and developer ergonomics.
Based on reviews from: G2, Glassdoor, Capterra, Optics.org, VCapital Management, AuntMinnie, accessdata.fda.gov, APIs.io Providers, Urology Times, AM Public Relations, Avenda Health News and Insights
Last updated: 2026-10-17
Videos
News, demos, and interviews about Avenda Health.
Videos load interactively. If none appear, search YouTube for Avenda Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Avenda Health.
Comparisons
When considering AI tools for your practice, it’s crucial to understand the distinct functionalities of Avenda Health’s Unfold AI and Fovia AI’s F.A.S.T. aiCockpit. Avenda Health’s Unfold AI is a specialized decision support software designed specifically for prostate cancer planning. It excels at creating detailed 3D cancer maps by integrating various patient data points, providing […]
When choosing between Avenda Health AI Prostate Cancer Planning Software and Infera, physicians should consider their primary need: highly specialized prostate cancer visualization and planning, or broad, point-of-care clinical decision support. Avenda Health’s Unfold AI is specifically designed for urology and oncology, generating detailed 3D cancer maps from various patient data points to precisely visualize […]
When considering AI tools for oncology, physicians can choose between solutions focused on specific clinical tasks, such as Avenda Health AI, or broader workflow enhancements, like Azra AI. Avenda Health AI’s Unfold AI software is designed for detailed prostate cancer treatment planning. It excels at generating 3D cancer estimation maps from various patient data sources, […]
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]